MetLife Investment Advisors LLC lowered its position in shares of Xylem Inc (NYSE:XYL) by 2.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 52,964 shares of the industrial products company’s stock after selling 1,172 shares during the quarter. MetLife Investment Advisors LLC’s holdings in Xylem were worth $3,569,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Perennial Advisors LLC grew its position in shares of Xylem by 1.9% in the second quarter. Perennial Advisors LLC now owns 36,114 shares of the industrial products company’s stock valued at $2,433,000 after purchasing an additional 681 shares in the last quarter. First Republic Investment Management Inc. grew its position in shares of Xylem by 1.8% in the first quarter. First Republic Investment Management Inc. now owns 40,838 shares of the industrial products company’s stock valued at $3,142,000 after purchasing an additional 724 shares in the last quarter. IFP Advisors Inc grew its position in shares of Xylem by 3.1% in the first quarter. IFP Advisors Inc now owns 23,970 shares of the industrial products company’s stock valued at $1,844,000 after purchasing an additional 729 shares in the last quarter. Stellar Capital Management LLC grew its position in shares of Xylem by 2.1% in the second quarter. Stellar Capital Management LLC now owns 39,820 shares of the industrial products company’s stock valued at $2,683,000 after purchasing an additional 805 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. grew its position in shares of Xylem by 3.2% in the first quarter. Nomura Asset Management Co. Ltd. now owns 27,174 shares of the industrial products company’s stock valued at $2,091,000 after purchasing an additional 831 shares in the last quarter. 85.85% of the stock is owned by institutional investors and hedge funds.

In other news, Director Curtis J. Crawford sold 7,500 shares of the firm’s stock in a transaction on Tuesday, August 7th. The stock was sold at an average price of $76.26, for a total transaction of $571,950.00. Following the completion of the transaction, the director now directly owns 40,421 shares in the company, valued at $3,082,505.46. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Paul A. Stellato sold 1,500 shares of the firm’s stock in a transaction on Wednesday, September 19th. The stock was sold at an average price of $82.00, for a total value of $123,000.00. Following the transaction, the insider now owns 12,796 shares of the company’s stock, valued at $1,049,272. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 49,284 shares of company stock valued at $3,839,982. Company insiders own 0.81% of the company’s stock.

A number of research firms have recently issued reports on XYL. Vertical Research lowered Xylem from a “hold” rating to a “sell” rating in a research report on Monday, October 8th. Canaccord Genuity set a $78.00 price objective on Xylem and gave the stock a “hold” rating in a research report on Tuesday, July 24th. Credit Suisse Group initiated coverage on Xylem in a research report on Friday. They issued an “outperform” rating and a $86.00 price objective for the company. Raymond James initiated coverage on Xylem in a research report on Wednesday, September 5th. They issued an “outperform” rating and a $90.00 price objective for the company. Finally, Robert W. Baird reiterated a “hold” rating and issued a $80.00 price objective on shares of Xylem in a research report on Wednesday, August 1st. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and nine have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $82.08.

Xylem stock traded up $0.73 during mid-day trading on Friday, hitting $69.77. The company’s stock had a trading volume of 1,885,515 shares, compared to its average volume of 1,099,460. Xylem Inc has a 1 year low of $62.24 and a 1 year high of $82.44. The firm has a market capitalization of $14.35 billion, a price-to-earnings ratio of 29.07, a PEG ratio of 1.52 and a beta of 1.22. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.02 and a current ratio of 1.43.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, July 31st. The industrial products company reported $0.73 EPS for the quarter, topping the consensus estimate of $0.71 by $0.02. Xylem had a return on equity of 19.04% and a net margin of 7.39%. The business had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.28 billion. During the same period last year, the business posted $0.59 earnings per share. The company’s quarterly revenue was up 13.1% on a year-over-year basis. Analysts forecast that Xylem Inc will post 2.91 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 7th. Stockholders of record on Thursday, November 1st will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Wednesday, October 31st. This represents a $0.84 annualized dividend and a dividend yield of 1.20%. Xylem’s dividend payout ratio is currently 35.00%.

Xylem Company Profile

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

Featured Article: Earnings Per Share (EPS) Explained

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.